True
Open Access
- 3 April 2000
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 82 (9) , 1535-1538
- https://doi.org/10.1054/bjoc.2000.1174
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- CA 125: A valid marker in ovarian carcinoma patients treated with paclitaxel?Cancer, 1996
- Preoperative Evaluation of D-Dimer and CA 125 Levels in Differentiating Benign from Malignant Ovarian MassesGynecologic Oncology, 1996
- Preoperative CA 125: An Independent Prognostic Factor in Patients With Stage I Epithelial Ovarian CancerObstetrics & Gynecology, 1995
- Exponential Regression of CA 125 during Salvage Treatment of Ovarian Cancer with TaxolGynecologic Oncology, 1994
- A Proposal to Use CA-125 to Evaluate Activity of New Antineoplastic Agents in Ovarian CancerGynecologic Oncology, 1993
- The prognostic value of serum CA 125 in patients with advanced ovarian carcinoma: an analysis of 573 patients by the Medical Research Council Working Party on Gynaecological CancerInternational Journal of Gynecologic Cancer, 1993
- Serum CA125 regression in epithelial ovarian cancer: Correlation with reassessment findings and survivalGynecologic Oncology, 1992
- Savings obtained by CA-125 measurements during therapy for ovarian carcinomaEuropean Journal Of Cancer, 1992
- CA 125 as an independent prognostic factor for survival in patients with epithelial ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1989
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983